Small Stocks, Big Money™

Venu Holding Corporation (NYSE American: VENU) capped 2024 with $77.7 million in Fire Pit Suite sales, including a stellar $11 million in December alone. These innovative, non-dilutive funding sources directly support VENU’s ambitious venue construction and expansion efforts, which includes $1.3 billion in active projects across Oklahoma, Texas, and beyond. By offering lifetime concert access with premium amenities to buyers, Fire Pit Suites provide a scalable funding source that fuels growth while preserving shareholder value. With sales projected to hit $200 million in 2025, VENU continues to redefine live entertainment and drive shareholder returns.

Gorilla Technology Group Inc. (Nasdaq: GRRR), in partnership with NC Digy Smart Cities and AECOM (NYSE: ACM), has signed a transformative MoU to turn Santa Marta into an AI-powered smart city. This 20-year project, supported by British and U.S. governments, integrates AI into urban infrastructure—enhancing public safety, mobility, and sustainability. By deploying advanced solutions like AI-driven lighting, cybersecurity nodes, and environmental sensors, the initiative sets a scalable model for smart city development across Latin America. With over 20 similar projects in discussion, Gorilla is positioned to lead regional urban innovation while leveraging Colombia's economic momentum from its recent energy boom.

Nova Minerals (Nasdaq: NVA) eliminated its US$5.42M debt with Nebari Gold Fund through a full conversion of the facility into equity, leaving the company debt-free and with ~A$16M (~US$9.9M) in cash reserves. This strategic move allows Nova to retain proceeds from its Snow Lake Resources sale and focus all capital on advancing its Estelle Gold and Critical Minerals Project in Alaska. The Estelle Project, with multi-million-ounce gold resources and promising antimony prospects, positions Nova as a key player in securing a U.S. domestic supply of critical minerals. Backed by Nebari as a shareholder, Nova is set for a transformational 2025.

BullFrog AI Holdings (Nasdaq: BFRG) will present its cutting-edge BullFrog Data Networks®, powered by the bfLEAP™ platform, at the Biotech Showcase and RESI JPM during JP Morgan Healthcare Conference Week in San Francisco, January 13–16, 2025. This proprietary AI tool transforms complex, multi-dimensional data into actionable insights, helping pharmaceutical companies accelerate drug discovery and optimize clinical trials. With proof of concept demonstrated in areas like colorectal cancer and neuropsychiatric disorders, BullFrog AI is poised to revolutionize drug development by reducing timelines and improving success rates.